Concepts (83)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tuberous Sclerosis | 1 | 2021 | 30 | 0.770 |
Why?
|
| Angiomyolipoma | 1 | 2021 | 17 | 0.770 |
Why?
|
| Critical Illness | 6 | 2023 | 317 | 0.640 |
Why?
|
| Education, Medical | 1 | 2020 | 244 | 0.570 |
Why?
|
| Kidney Neoplasms | 1 | 2021 | 526 | 0.540 |
Why?
|
| Internship and Residency | 2 | 2020 | 1073 | 0.450 |
Why?
|
| Multiple Organ Failure | 3 | 2023 | 55 | 0.440 |
Why?
|
| Resuscitation | 2 | 2023 | 111 | 0.380 |
Why?
|
| Intensive Care Units, Pediatric | 4 | 2022 | 109 | 0.300 |
Why?
|
| Respiration, Artificial | 2 | 2022 | 361 | 0.300 |
Why?
|
| Child | 10 | 2023 | 7273 | 0.290 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 322 | 0.260 |
Why?
|
| Systemic Inflammatory Response Syndrome | 2 | 2022 | 53 | 0.240 |
Why?
|
| Fluid Therapy | 2 | 2023 | 52 | 0.230 |
Why?
|
| Shock, Septic | 1 | 2023 | 105 | 0.200 |
Why?
|
| Hypernatremia | 1 | 2021 | 9 | 0.190 |
Why?
|
| Brain Diseases | 1 | 2023 | 191 | 0.190 |
Why?
|
| Child, Hospitalized | 1 | 2022 | 36 | 0.190 |
Why?
|
| Knowledge | 1 | 2020 | 28 | 0.180 |
Why?
|
| Myocarditis | 1 | 2020 | 52 | 0.170 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2021 | 121 | 0.170 |
Why?
|
| Herpes Simplex | 1 | 2021 | 203 | 0.170 |
Why?
|
| Education, Distance | 1 | 2020 | 25 | 0.170 |
Why?
|
| Sepsis | 1 | 2023 | 330 | 0.160 |
Why?
|
| Hospital Mortality | 3 | 2022 | 433 | 0.150 |
Why?
|
| Humans | 15 | 2023 | 91074 | 0.130 |
Why?
|
| Atrial Fibrillation | 1 | 2020 | 361 | 0.130 |
Why?
|
| Curriculum | 1 | 2020 | 576 | 0.130 |
Why?
|
| Pediatrics | 1 | 2020 | 366 | 0.120 |
Why?
|
| Adolescent | 6 | 2022 | 9411 | 0.120 |
Why?
|
| Clinical Competence | 1 | 2020 | 800 | 0.110 |
Why?
|
| Child, Preschool | 3 | 2022 | 3790 | 0.110 |
Why?
|
| Retrospective Studies | 6 | 2022 | 9400 | 0.110 |
Why?
|
| Age Factors | 2 | 2022 | 1876 | 0.100 |
Why?
|
| Infant, Newborn | 2 | 2021 | 2510 | 0.090 |
Why?
|
| Infant | 2 | 2022 | 3204 | 0.080 |
Why?
|
| Critical Care | 2 | 2023 | 391 | 0.080 |
Why?
|
| Prevalence | 1 | 2020 | 1265 | 0.070 |
Why?
|
| Female | 7 | 2022 | 47186 | 0.060 |
Why?
|
| Cross-Sectional Studies | 1 | 2020 | 1753 | 0.060 |
Why?
|
| Nootropic Agents | 1 | 2003 | 10 | 0.060 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2003 | 45 | 0.050 |
Why?
|
| Down Syndrome | 1 | 2003 | 55 | 0.050 |
Why?
|
| Indans | 1 | 2003 | 35 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2023 | 104 | 0.050 |
Why?
|
| Risk Assessment | 1 | 2020 | 2345 | 0.050 |
Why?
|
| Piperidines | 1 | 2003 | 164 | 0.050 |
Why?
|
| Male | 5 | 2022 | 43249 | 0.050 |
Why?
|
| Cognition Disorders | 1 | 2003 | 236 | 0.050 |
Why?
|
| Oxygen Inhalation Therapy | 1 | 2022 | 60 | 0.050 |
Why?
|
| Time Factors | 1 | 2020 | 5378 | 0.050 |
Why?
|
| Water-Electrolyte Imbalance | 1 | 2021 | 15 | 0.050 |
Why?
|
| Acyclovir | 1 | 2021 | 108 | 0.050 |
Why?
|
| Cluster Analysis | 1 | 2021 | 373 | 0.040 |
Why?
|
| Risk Factors | 1 | 2020 | 5608 | 0.040 |
Why?
|
| Consensus | 1 | 2021 | 374 | 0.040 |
Why?
|
| Cross-Over Studies | 1 | 2020 | 388 | 0.040 |
Why?
|
| Machine Learning | 1 | 2021 | 278 | 0.040 |
Why?
|
| Body Mass Index | 1 | 2022 | 784 | 0.040 |
Why?
|
| Intensive Care Units | 1 | 2022 | 407 | 0.040 |
Why?
|
| Electrocardiography | 1 | 2020 | 498 | 0.040 |
Why?
|
| Logistic Models | 1 | 2022 | 1216 | 0.040 |
Why?
|
| Simulation Training | 1 | 2020 | 105 | 0.040 |
Why?
|
| Comorbidity | 1 | 2022 | 963 | 0.040 |
Why?
|
| Hypoxia | 1 | 2023 | 660 | 0.040 |
Why?
|
| Antiviral Agents | 1 | 2021 | 490 | 0.040 |
Why?
|
| Oxygen | 1 | 2022 | 746 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2023 | 2785 | 0.030 |
Why?
|
| Registries | 1 | 2021 | 826 | 0.030 |
Why?
|
| Phenotype | 1 | 2023 | 2480 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2022 | 2904 | 0.030 |
Why?
|
| Hospitalization | 1 | 2021 | 903 | 0.030 |
Why?
|
| Pregnancy | 1 | 2021 | 3079 | 0.030 |
Why?
|
| Adult | 3 | 2020 | 27147 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2020 | 4367 | 0.020 |
Why?
|
| Young Adult | 1 | 2020 | 6502 | 0.020 |
Why?
|
| Language Development Disorders | 1 | 2003 | 24 | 0.010 |
Why?
|
| Drug Administration Schedule | 1 | 2003 | 866 | 0.010 |
Why?
|
| Neuropsychological Tests | 1 | 2003 | 516 | 0.010 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2003 | 1935 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2003 | 1738 | 0.010 |
Why?
|
| Treatment Outcome | 1 | 2003 | 8436 | 0.010 |
Why?
|
| Middle Aged | 1 | 2003 | 26555 | 0.000 |
Why?
|